This post is from a suggested group
Carotid Stents Market: Balancing Minimally Invasive Intervention Against Surgical Risk for Carotid Artery Stenosis and Stroke Prevention
The Carotid Stents Market is strategically positioned at the nexus of cardiovascular and neurological health, offering a minimally invasive, endovascular alternative to Carotid Endarterectomy (CEA) for treating carotid artery stenosis, thereby preventing ischemic stroke, and necessitates a focused group discussion on evolving clinical guidelines. The primary driver for market growth is the soaring global prevalence of risk factors such as atherosclerosis, hypertension, diabetes, and obesity, all contributing to the build-up of plaque in the carotid arteries. As the global geriatric population expands, so does the pool of patients requiring intervention. Carotid Artery Stenting (CAS) is favored by many patients and clinicians over open surgery due to its advantages: shorter hospital stays, quicker recovery times, and reduced physical trauma. Technological advances are key, including the development of sophisticated, next-generation stent designs and, critically, improved…